Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma

Fig. 5

Changes in body temperature and AFP. a After ten-day administration of sorafenib, the patient suffered from high fever from Mar. 29th, 2015. Upon cease of sorafenib use on Apr. 3rd, 2015, the high fever decreased quickly. After taking sorafenib again at Apr. 7th, and the fever developed. After daily administration of prednisone, the body temperature returned to the normal. b The serum AFP gradually dropped from 24793 ng/mL to 2.19 ng/mL from March 16th, 2015 to Apr. 12th, 2016

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us